Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/22
Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022GlobeNewsWire • 05/05/22
Wave Life Sciences Announces Publication of Foundational Preclinical Data Supporting Development of WVE-004 for C9orf72-associated ALS and FTDGlobeNewsWire • 04/25/22
Wave Life Sciences to Present at Chardan's 6th Annual Genetic Medicines and Cell Therapy Manufacturing SummitGlobeNewsWire • 04/19/22
Wave Life Sciences Jump As Low Doses of WVE-004 Lowers Disease Biomarker In Neurological IndicationsBenzinga • 04/04/22
Wave Life Sciences Announces Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004GlobeNewsWire • 04/04/22
Wave Life Sciences to Highlight RNA Base Editing Modality and Alpha-1 Antitrypsin Deficiency Program at Upcoming Scientific and Industry MeetingsGlobeNewsWire • 03/15/22
Wave Life Sciences Announces Nature Biotechnology Publication Highlighting First RNA Base Editing in Non-Human Primates Using an Endogenous EnzymeGlobeNewsWire • 03/07/22
Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/03/22
Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/03/22
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022GlobeNewsWire • 02/24/22
Wave Life Sciences to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference 2022GlobeNewsWire • 02/09/22
Wave Life Sciences Announces Two Papers in the Journal Nucleic Acids Research Describing How PN Backbone Chemistry Modifications Enhance the Pharmacological Effects of OligonucleotidesGlobeNewsWire • 02/02/22
ADDF and AFTD Partner to Support Wave Life Sciences' FTD and ALS Clinical ProgramPRNewsWire • 01/25/22
Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/21
Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare ConferenceGlobeNewsWire • 11/08/21
Will Wave Life Sciences (WVE) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 11/01/21
Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021GlobeNewsWire • 11/01/21